Neutropenia during Revolade treatment in a patient with chronic ITP

revolade   Dan revolade

Eltrombopag is sold under the brand name Revolade outside the US and is marketed by Novartis It is a thrombopoietin receptor agonist It is taken by mouth

Revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia lasting 6 months or longer from Initial dose regimen: Adults: Revolade should be initiated at a dose of 25 mg once daily For chronic HCV patients of East-Southeast-Asian ancestry, Revolade

shraddha kapoor age 2024 Revolade Tablet 25 mg is a product of Novartis Ltd Its generic name is Eltrombopag Olamine  Revolade 50 mg Tablet is used to treat low blood platelet count in patients with idiopathic thrombocytopenic purpura and hepatitis C virus